Agenda item 2 is consideration of continued petitions. PE1408, from Andrea MacArthur, calls on the Scottish Parliament to urge the Scottish Government to review and overhaul the current outdated and ineffective method of diagnosing and treating pernicious anaemia and vitamin B12 deficiency.
Members will recall that, when we last considered this petition in October, we agreed to write to the Scottish Government to ask whether the recently established haematology short-life working group would meet the petitioner and keep her informed of the progress of its work. The petitioner met the short-life working group in February and described the meeting as “a very positive experience”. The petitioner also confirmed that the working group would continue to liaise with her.
The petitioner’s submission highlights two specific issues outwith the control of the working group in relation to vitamin B12 injections, more details of which are contained in our meeting papers. The petitioner has contacted the appropriate stakeholders in relation to these issues and has been advised that there are concerns relating to the safety and efficacy of the injections as well as the inability to change the licence for the vaccination. As members will be aware, issues to do with the licensing of medicines are outwith the Parliament’s purview.
Do members have any suggestions on how we might take this forward?
We have probably gone as far as we can with this petition. The responses make it fairly clear that matters with regard to relicensing, changing the licensing position and the efficacy of injecting are all outwith devolved powers, so we would just run into problems further on that we could not solve. I believe that the responses are quite rational and I think the petitioner probably needs to be satisfied with where things sit at the moment.
This is another petition that has been on-going for some time—in this case, since 2011. It is good that some progress has been made, and I am pleased that, as the convener has mentioned, the petitioner had a very positive meeting with representatives of the short-life working group. It is also encouraging that the group pointed the petitioner in the direction of appropriate stakeholders to try to address the two outstanding issues. I agree with Michelle Ballantyne that given the progress that has been made—although not complete—we should close the petition. After all, we can take it no further at this stage.
I am totally content. We should look on it as a partial success story, given that the petitioner will be liaising with the short-life working group and is appreciative of that. As has been said, we have taken this as far as we can. Now that the petitioner is engaging with people who can effect change, we should close the petition.
If that is the case, I propose that we close the petition, under rule 15.7 of the standing orders, on the basis that the petitioner has met the haematology short-life working group and that the group has committed to continue to liaise with her. In recognition of the response that she has received, we want to thank the petitioner for highlighting these issues and for her persistence in pursuing them. Do members agree?
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.